In addition, elevated expression of IL4Rα and/or IL13Rα1 were associated with poor prognosis of glioblastoma [9], mesothelioma [10], breast cancer [11], renal cell carcinoma [12], and oral cavity squamous cell carcinoma patients [13]. This evidence concerns the gene IL13RA1 and breast cancer.